
Glimepiride (3mg) + Metformin (1000mg)
Active composition
+1 more active ingredient
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Jubiglim M Forte 3mg/1000mg Tablet PR is a combination oral antidiabetic medication containing Glimepiride 3mg and Metformin 1000mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, stimulates pancreatic beta cells to increase insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity, promoting better glucose uptake and utilization. The combination is beneficial for patients inadequately controlled on monotherapy or those requiring dual therapy to achieve optimal glycemic targets. Jubiglim M Forte is intended for use alongside diet and exercise to improve blood glucose regulation. It is contraindicated in patients with severe renal impairment, metabolic acidosis, or known hypersensitivity to either component. Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea, as well as hypoglycemia due to glimepiride. Regular monitoring of blood glucose, renal function, and liver enzymes is recommended during therapy. Dose adjustments should be individualized based on therapeutic response and tolerability. This formulation provides a convenient and effective option for comprehensive glycemic management in type 2 diabetes.
How to use Jubiglim M Tablet PR Use it as advised by your doctor or check the label for directions before use. Jubiglim M Forte 3mg/1000mg Tablet PR is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Jubiglim M Forte 3mg/1000mg Tablet PR.
High Risk
Jubiglim M Forte 3mg/1000mg Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Jubiglim M Forte 3mg/1000mg Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Jubiglim M Forte 3mg/1000mg Tablet PR may be needed. Please consult your doctor. Jubiglim M Forte 3mg/1000mg Tablet PR is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease.
Regular Checkup
Jubiglim M Forte 3mg/1000mg Tablet PR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Jubiglim M Forte 3mg/1000mg Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Jubiglim M Forte 3mg/1000mg Tablet PR may be needed. Please consult your doctor. Use of Jubiglim M Forte 3mg/1000mg Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Jubiglim M Forte 3mg/1000mg Tablet PR

Glimepiride (3mg) + Metformin (1000mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Jubiglim M Forte 3mg/1000mg Tablet PR is a combination oral antidiabetic medication containing Glimepiride 3mg and Metformin 1000mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, stimulates pancreatic beta cells to increase insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity, promoting better glucose uptake and utilization. The combination is beneficial for patients inadequately controlled on monotherapy or those requiring dual therapy to achieve optimal glycemic targets. Jubiglim M Forte is intended for use alongside diet and exercise to improve blood glucose regulation. It is contraindicated in patients with severe renal impairment, metabolic acidosis, or known hypersensitivity to either component. Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea, as well as hypoglycemia due to glimepiride. Regular monitoring of blood glucose, renal function, and liver enzymes is recommended during therapy. Dose adjustments should be individualized based on therapeutic response and tolerability. This formulation provides a convenient and effective option for comprehensive glycemic management in type 2 diabetes.
How to use Jubiglim M Tablet PR Use it as advised by your doctor or check the label for directions before use. Jubiglim M Forte 3mg/1000mg Tablet PR is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Jubiglim M Forte 3mg/1000mg Tablet PR.
High Risk
Jubiglim M Forte 3mg/1000mg Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Jubiglim M Forte 3mg/1000mg Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Jubiglim M Forte 3mg/1000mg Tablet PR may be needed. Please consult your doctor. Jubiglim M Forte 3mg/1000mg Tablet PR is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease.
Regular Checkup
Jubiglim M Forte 3mg/1000mg Tablet PR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Jubiglim M Forte 3mg/1000mg Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Jubiglim M Forte 3mg/1000mg Tablet PR may be needed. Please consult your doctor. Use of Jubiglim M Forte 3mg/1000mg Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Jubiglim M Forte 3mg/1000mg Tablet PR













